Grindr to Acquire PurposeMed for $250 Million in Healthcare Expansion

Grindr will pay $190 million in cash and $60 million in Grindr common stock, according to the terms. The agreement includes up to $70 million in additional cash consideration tied to Freddie's performance in 2027, payable in 2028. The acquisition is expected to close in the fourth quarter.

CNBC reported that the deal is Grindr's first major acquisition since the company was founded in 2009. CEO George Arison told CNBC that Grindr now has a second business line that it believes will be as profitable as the core business and could be the same size or larger.

Grindr has been building Woodwork, its LGBTQ healthcare platform launched in 2025, into a larger source of revenue alongside subscriptions and advertising. Arison said Grindr could have built the offering itself, but it would have taken two to three years to reach the same scale. He said the company needs pharmacies and clinicians to fulfill care, and that utilization and margins improve as more patients join.

Grindr expects the combined U.S. telehealth and pharmacy business to generate more than $400 in monthly revenue per active patient, or more than $4,800 annually for a patient who remains in care for a full year. At a scale of 50,000 U.S. patients, Arison estimates the business could represent roughly $240 million in annual revenue.

"We're doing exactly what we promised the street," Arison said. "I hope people view us as a platform company that is not just an online business, but rather multiple lines of business with a community that really cares about this product, and we care about them."

Grindr said the acquisition is expected to be immediately accretive to its EBITDA dollars, but the investments needed to build out the U.S. operation will initially weigh on margins. The company plans to share more details with shareholders in November about how much capital it will invest to grow the business. Arison expects margins to improve with scale and eventually approach the more than 40% margins of its core business.

Freddie was founded in Canada in 2020 and expanded into the United States in 2024. It now serves patients in all 50 states and Washington, D.C., and has served more than 55,000 patients in the U.S. and Canada, according to Grindr. It provides telehealth services, testing, prescriptions and medication delivery.

The acquisition gives Grindr a way to integrate those services into its app, which is used by millions of people globally. Grindr estimates that about 400,000 U.S. users currently indicate on their profiles that they take PrEP, while more than two million additional U.S. users could benefit from the medication. PrEP, or pre-exposure prophylaxis, can reduce the risk of acquiring HIV from sex by 99% when taken as prescribed. Under the new model, users will be able to learn about PrEP, review coverage, connect with clinicians, arrange testing, obtain prescriptions and manage refills on the Grindr platform.

Arison said his goal is to take the 10% annual growth in PrEP use that Grindr sees today and perhaps double it. He said that would add about 300,000 more people on PrEP over the next five years, which he described as roughly 5,000 patients not getting HIV.

The healthcare expansion comes as investors have focused on how Grindr can diversify monetization beyond its core business. Morgan Stanley analyst Nathan Feather described Grindr in a July note as an underappreciated company with strong network effects, high engagement and significant profitability. The firm upgraded the stock to overweight from equal weight and raised its price target from $16 to $18, citing potential for greater product-led monetization. Grindr shares closed Wednesday at $15.43.